Ultralife Valuation
| ULB Stock | EUR 4.69 0.13 2.70% |
At this time, the company appears to be undervalued. Ultralife has a current Real Value of €4.91 per share. The regular price of the company is €4.69. Our model measures the value of Ultralife from inspecting the company fundamentals such as Return On Equity of 0.0128, shares outstanding of 16.64 M, and Operating Margin of (0.01) % as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 0.8119 | Enterprise Value 130.8 M | Enterprise Value Ebitda 12.3879 | Price Sales 0.436 | Forward PE 15.1976 |
Undervalued
Today
Please note that Ultralife's price fluctuation is slightly risky at this time. Calculation of the real value of Ultralife is based on 3 months time horizon. Increasing Ultralife's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ultralife stock is determined by what a typical buyer is willing to pay for full or partial control of Ultralife. Since Ultralife is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ultralife Stock. However, Ultralife's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.69 | Real 4.91 | Hype 4.7 | Naive 4.65 |
The real value of Ultralife Stock, also known as its intrinsic value, is the underlying worth of Ultralife Company, which is reflected in its stock price. It is based on Ultralife's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ultralife's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ultralife helps investors to forecast how Ultralife stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ultralife more accurately as focusing exclusively on Ultralife's fundamentals will not take into account other important factors: Ultralife Cash |
|
Ultralife Total Value Analysis
Ultralife is at this time estimated to have takeover price of 130.79 M with market capitalization of 81.33 M, debt of 2.75 M, and cash on hands of 21.24 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ultralife fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
130.79 M | 81.33 M | 2.75 M | 21.24 M |
Ultralife Investor Information
About 73.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.81. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Ultralife had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Ultralife's historical financial statements, Ultralife is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 6 M | 11.5 M |
|
|
Ultralife Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ultralife has an asset utilization ratio of 74.6 percent. This implies that the Company is making €0.75 for each dollar of assets. An increasing asset utilization means that Ultralife is more efficient with each dollar of assets it utilizes for everyday operations.Ultralife Profitability Analysis
Based on the measurements of profitability obtained from Ultralife's financial statements, Ultralife may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Ultralife's ability to earn profits and add value for shareholders.Net Income | First Reported 2019-09-30 | Previous Quarter 879 K | Current Value -1.2 M | Quarterly Volatility 1.3 M |
For Ultralife profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ultralife to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ultralife utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ultralife's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ultralife over time as well as its relative position and ranking within its peers.
Ultralife Earnings per Share Projection vs Actual
By analyzing Ultralife's earnings estimates, investors can diagnose different trends across Ultralife's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Ultralife is based on EPS before non-recurring items and includes expenses related to employee stock options.Ultralife Ownership Allocation
Ultralife shows a total of 16.64 Million outstanding shares. The majority of Ultralife outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Ultralife to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Ultralife. Please pay attention to any change in the institutional holdings of Ultralife as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Ultralife Profitability Analysis
The company reported the revenue of 164.46 M. Net Income was 6.31 M with profit before overhead, payroll, taxes, and interest of 44.56 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ultralife's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ultralife and how it compares across the competition.
About Ultralife Valuation
The stock valuation mechanism determines Ultralife's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ultralife. We calculate exposure to Ultralife's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ultralife's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 48.7 M | 33.3 M |
Complementary Tools for Ultralife Stock analysis
When running Ultralife's price analysis, check to measure Ultralife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultralife is operating at the current time. Most of Ultralife's value examination focuses on studying past and present price action to predict the probability of Ultralife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultralife's price. Additionally, you may evaluate how the addition of Ultralife to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |